ABC | Volume 111, Nº4, Octuber 2018

Original Article de Souza e Silva et al Percutaneous coronary intervention in the State of Rio de Janeiro Arq Bras Cardiol. 2018; 111(4):553-561 1. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256. 2. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-causemortality, and cause-specificmortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-544. 3. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232-45. 4. Organization for Economic Cooperation andDevelopment. (OECD). Health at a Glance 2015: OECD Indicators, OECD Publishing Paris; 2015. 5. Grech ED. ABC of interventional cardiology: percutaneous coronary intervention. I: history and development. BMJ. 2003;326(7398):1080-2. 6. Switaj TL, Christensen SR, Brewer DM. Acute coronary syndrome: current treatment. Am Fam Physician. 2017;95(4):232-40. 7. Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with sTABELA ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on PracticeGuidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2014;130(19):1749-67. 8. Marso SP, Teirstein PS, Kereiakes DJ, Moses J, Lasala J, Grantham JA. Percutaneous coronary intervention use in the United States: defining measures of appropriateness. JACC Cardiovasc Interv. 2012;5(2):229-35. 9. de Souza e Silva CG, Klein CH, Godoy PH, de Souza e Silva NA. Trends and hospital mortality in myocardial revascularization procedures covered by the Brazilian Unified Health System in Rio de Janeiro State from 1999 to 2010. Int J Cardiovasc Sci. 2016;29(6):477-91. 10. Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With STABELA Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2017;69(17):2212-41. 11. Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, et al; ORBITA investigators. Percutaneous coronary intervention in sTABELA angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391(10115):31-40. Erratum in: Lancet. 2018;391(10115):30. 12. Silverman SL. From randomized controlled trials to observational studies. Am J Med. 2009;122(2):114-20. 13. Huynh T, Perron S, O’Loughlin J, Joseph L, Labrecque M, Tu JV, et al. Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infaECAion: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies. Circulation. 2009;119(24):3101-9. 14. Marques RM, Piola S, Carrillo Roa A. Health system in Brazil: organization and financing. Rio de Janeiro: ABrES; Brasília: Ministério da Saúde, Departamento de Economia da Saúde, Investimentos e Desenvolvimento; OPAS/OMS no Brasil; 2016. 15. Brasil. Ministério da Saúde [Internet]. Datasus. Informações de saúde – epidemiológicas e mortalidade [Accessed Jun 2, 2017]. Available at: http:// www2.datasus.gov.br 16. Brasil. Ministério da Saúde [Internet]. Sistema Nacional de Auditoria. Departamento Nacional de Auditoria do SUS [Accessed Jun 2, 2017]. Available at: http://sna.saude.gov.br. 17. World Health Organization. (WHO). The ICD-10 Classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva; 1992. 18. Brasil. Ministério da Saúde [Internet]. Agência Nacional de Saúde Suplementar (ANS). Perfil do setor – dados e indicadores do setor [Accessed May 25, 2017]. Available at: http://www.ans.gov.br 19. BavishiC,BangaloreS,PatelD,ChatterjeeS,TrivediV,Tamis-HollandJE.Short and long-termmortality inwomenandmenundergoingprimaryangioplasty: A comprehensive meta-analysis. Int J Cardiol. 2015 Nov 1;198:123-30. 20. Heer T, Hochadel M, Schmidt K, Mehilli J, Zahn R, Kuck KH, et al. Sex differences in percutaneous coronary intervention-insights from the coronary angiography and ICP registry of the German Society of Cardiology. J AmHeart Assoc. 2017;6(3).pii: e004972. 21. Danchin N, Ferrieres J, Guenoun M, Cattan S, Rushton-Smith SK, Greenlaw N, et al; CLARIFY Investigators. Management of outpatients in France with sTABELAcoronaryarterydisease.FindingsfromtheprospeCtiveobservational LongitudinAl RegIstry oF patients with sTABELA coronary arterY disease (CLARIFY) registry. Arch Cardiovasc Dis. 2014;107(8-9):452-61. 22. Kunadian V, Qiu W, Lagerqvist B, Johnston N, Sinclair H, Tan Y, et al; National Institute for Cardiovascular Outcomes Research and Swedish Coronary Angiography and Angioplasty Registries. Gender differences in outcomes and predictors of all-causemortality after percutaneous coronary intervention (Data from United Kingdom and Sweden). Am J Cardiol. 2017;119(2):210-6. 23. Berger JS,SanbornTA,ShermanW,BrownDL. Influenceofsexon in-hospital outcomesand long-termsurvivalaftercontemporarypercutaneouscoronary intervention. AmHeart J. 2006;151(5):1026-31. 24. Jacobs AK, Kelsey SF, Brooks MM, Faxon DP, Chaitman BR, Bittner V, et al. Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI). Circulation. 1998;98(13):1279-85. 25. Instituto Brasileiro de Geografia e Estatítica (IBGE). Tábua completa de mortalidade para o Brasil – 2015: Breve análise da evolução damortalidade no Brasil [Accessed May 23, 2017]. Available at: http://www.ibge.gov.br 26. Langørgen J, Igland J, Vollset SE, Averina M, Nordrehaug JE, Tell GS, et al. Short-term and long-term case fatality in 11 878 patients hospitalized with a first acute myocardial infaECAion, 1979-2001: the Western Norway cardiovascular registry. Eur J Cardiovasc Prev Rehabil. 2009;16(5):621-7. 27. Isaksson RM, Jansson JH, Lundblad D, Näslund U, Zingmark K, Eliasson M. Better long-term survival in young and middle-aged women than in men after a first myocardial infaECAion between 1985 and 2006. An analysis of 8630 patients in the northern Sweden MONICA study. BMC Cardiovasc Disord. 2011 Jan 5;11:1. 28. Feldman DN, Gade CL, Slotwiner AJ, Parikh M, Bergman G, Wong SC, et al; New York State Angioplasty Registry. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry). Am J Cardiol. 2006;98(10):1334-9. 29. HlatkyMA, BoothroydDB, Bravata DM, Boersma E, Booth J, Brooks MM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373(9670):1190-7. 30. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994;331(8):496-501. References 560